ACE2 in SARS-CoV-2-Mediated COVID-19: A Brief Review
Trends in Medical Sciences · 2022
DOI: 10.5812/tms-130682 ↗Kurz gefasst
Fachartikel in der Zeitschrift Trends in Medical Sciences, 2022. Verfasst von Pooria Safarzadeh Kozani und 10 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
: Angiotensin-converting enzyme 2 (ACE2) is widely known as the essential receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 is the cause of the globally known coronavirus disease 2019 (COVID-19) pandemic, which has been the leading cause of virus-related mortality since early 2020. A wide range of human cells in different human organs express ACE2. The importance of ACE2 in the involvement of human organs during COVID-19 and its critical role in the process of target cell infection have rendered it an interesting therapeutic target. In this review, we briefly focus on ACE2 and its general roles in the human body and highlight the roles of ACE2 in the emergence of COVID19. Ultimately, we discuss the strategies for preventing virus entry using ACE2 blocking.
Zitieren
APA
Kozani, P. S., Shokoohi, S. D., Baharifar, N., Sheikhi, S., Shamsabadi, F. K., Nejad, F. C., Sheikhi, M., Valashedi, M. R., Kozani, P. S., Mirarefin, S. M. J., & Sheikhi, A. (2022). ACE2 in SARS-CoV-2-Mediated COVID-19: A Brief Review. Trends in Medical Sciences. https://doi.org/10.5812/tms-130682
Vancouver
Kozani PS, Shokoohi SD, Baharifar N, Sheikhi S, Shamsabadi FK, Nejad FC, et al. ACE2 in SARS-CoV-2-Mediated COVID-19: A Brief Review. Trends in Medical Sciences. 2022. doi:10.5812/tms-130682
BibTeX
@article{Kozani2022,
author = {Kozani, Pooria Safarzadeh and Shokoohi, Setareh Dashti and Baharifar, Narges and Sheikhi, Sepideh and Shamsabadi, Fatemeh Khalaf and Nejad, Forough Chamaie and Sheikhi, Mehdi and Valashedi, Mehdi Rabiee and Kozani, Pouya Safarzadeh and Mirarefin, Seyed Mohamad Javad and Sheikhi, Abdolkarim},
title = {ACE2 in SARS-CoV-2-Mediated COVID-19: A Brief Review},
journal = {Trends in Medical Sciences},
year = {2022},
doi = {10.5812/tms-130682}
}
EUVIMED